Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04663971Recruiting

Fertility and Pregnancy After Surgery IBD Audit

Role: collaborator

NCT05431283Unknown

Real-world Effectiveness of Tofacitinib on Ulcerative Colitis Associated Spondyloarthropathy

Role: lead

NCT04769258Unknown

Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD)

Role: lead

NCT04587141Phase 3Unknown

Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial

Role: collaborator

NCT03150238Unknown

Surgically Resected Crohn's Disease Patients: Prognostic Factors for Re-operation and New Score Building

Role: collaborator

All 5 trials loaded